Helix Biopharma Corp. Completes Common Share Private Placement

Business Wire, May 31, 1996

VANCOUVER, British Columbia--(BUSINESS WIRE)--May 31, 1996--HELIX BIOPHARMA (VSE:HBP)

TSE Listing

Helix BioPharma Corp. ("Helix BioPharma") is pleased to announce that the Toronto Stock Exchange has approved the listing of the Company's common shares on the Exchange. Trading will commence at the opening on Monday, June 3, 1996. Private Placement

Further to the Company's news release of May 3, 1996, the Company has successfully closed the private placement in the amount of $1.6 million with a select group of European investors. The Company has received VSE approval for the transaction and the listing of the Company's shares on the TSE satisfies the conditions for the release of funds. The Company will issue a total of 800,000 common shares at $2.00 per share. Proceeds of the placement will be used for general working capital. A finders fee of $70,000 plus 17,500 common shares is payable. Dated at Richmond, B.C. this 31st Day of May, 1996. -0-

NOTE: The Vancouver Stock Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. Helix BioPharma trades on the VSE under the symbol "HBP".

CONTACT: Helix Biopharma Corp.

Jason Van Bergen, 604/270-7468